What does CUSIP 462260100 represent in this 13F holders report?

CUSIP 462260100 is the security identifier for IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK in Q1 2024?

266 institutional investors reported IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK for Q1 2024. Use the holders table for investor-level position and value details.

IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA)

CUSIP: 462260100

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / COMMON STOCK
Shares outstanding: 415,431,143
Total 13F shares: 217,101,064
Share change: +10,250,604
Total reported value: $3,216,301,753
Put/Call ratio: 53%
Price per share: $14.82
Number of holders: 266
Value change: +$212,421,390
Number of buys: 155
Number of sells: 112

Quarterly Holders Quick Answers

What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 462260100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Wayne P. Rothbaum	3/4/5	Director	— mixed-class rows	28,167,333 mixed-class rows	$257,731,097	—	01 Mar 2024	3/4/5
VANGUARD GROUP INC	13F	Company	5.5%	22,812,820	$185,468,227	—	31 Dec 2023	13F
MHR FUND MANAGEMENT LLC	13F	Company	4.8%	19,997,103	$162,576,447	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	4.6%	19,071,756	$155,053,376	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	4%	16,424,388	$133,530,274	—	31 Dec 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	2.9%	11,979,415	$97,392,643	—	31 Dec 2023	13F
Avoro Capital Advisors LLC	13F	Company	1.6%	6,700,000	$54,471,000	—	31 Dec 2023	13F
Pictet Asset Management Holding SA	13F	Company	1.3%	5,263,309	$42,790,702	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	5,037,098	$40,956,054	—	31 Dec 2023	13F
Artisan Partners Limited Partnership	13F	Company	1.2%	4,827,670	$39,248,957	—	31 Dec 2023	13F
ORBIMED ADVISORS LLC	13F	Company	1.1%	4,707,458	$38,271,634	—	31 Dec 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.95%	3,926,159	$31,919,673	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.89%	3,715,545	$30,207,381	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.89%	3,681,560	$29,931,082	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.85%	3,516,987	$28,598,901	—	31 Dec 2023	13F
MPM BioImpact LLC	13F	Company	0.79%	3,289,470	$26,743,391	—	31 Dec 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.79%	3,276,602	$26,640,000	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.68%	2,839,667	$23,086,493	—	31 Dec 2023	13F
CREDIT SUISSE AG/	13F	Company	0.68%	2,814,316	$22,880,390	—	31 Dec 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.63%	2,636,327	$21,433,338	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.53%	2,182,877	$17,746,789	—	31 Dec 2023	13F
Long Focus Capital Management, LLC	13F	Company	0.51%	2,135,521	$17,361,786	—	31 Dec 2023	13F
Palo Alto Investors LP	13F	Company	0.51%	2,106,792	$17,128,219	—	31 Dec 2023	13F
Hood River Capital Management LLC	13F	Company	0.48%	2,001,510	$16,272,276	—	31 Dec 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.46%	1,915,412	$15,572,300	—	31 Dec 2023	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.42%	1,750,907	$14,234,874	—	31 Dec 2023	13F
683 Capital Management, LLC	13F	Company	0.42%	1,750,000	$14,227,500	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.42%	1,747,023	$14,203,297	—	31 Dec 2023	13F
S.c.a. Candriam	13F	Individual	0.42%	1,727,822	$14,047,829	—	31 Dec 2023	13F
Woodline Partners LP	13F	Company	0.39%	1,604,706	$13,046,260	—	31 Dec 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.38%	1,598,930	$12,999,301	—	31 Dec 2023	13F
Boxer Capital, LLC	13F	Company	0.34%	1,400,000	$11,382,000	—	31 Dec 2023	13F
C WorldWide Group Holding A/S	13F	Company	0.33%	1,360,000	$11,057,000	—	31 Dec 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.3%	1,247,515	$10,142,297	—	31 Dec 2023	13F
NORGES BANK	13F	Company	0.27%	1,120,457	$9,109,315	—	31 Dec 2023	13F
Rhenman & Partners Asset Management AB	13F	Company	0.27%	1,116,818	$9,079,730	—	31 Dec 2023	13F
Invenomic Capital Management LP	13F	Company	0.25%	1,053,251	$8,562,931	—	31 Dec 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.25%	1,021,824	$8,307,429	—	31 Dec 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.25%	1,021,818	$8,307,380	—	31 Dec 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.24%	1,000,000	$8,130,000	—	31 Dec 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.24%	983,080	$7,992,440	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.23%	945,892	$7,690,103	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.23%	939,546	$7,638,509	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.23%	936,887	$7,616,892	—	31 Dec 2023	13F
Opaleye Management Inc.	13F	Company	0.22%	897,000	$7,292,610	—	31 Dec 2023	13F
UBS Group AG	13F	Company	0.21%	857,308	$6,969,914	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.2%	850,205	$6,912,169	—	31 Dec 2023	13F
Invesco Ltd.	13F	Company	0.2%	837,158	$6,806,095	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.2%	836,175	$6,798,103	—	31 Dec 2023	13F
BANQUE PICTET & CIE SA	13F	Company	0.19%	778,038	$6,325,449	—	31 Dec 2023	13F

Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) as of Q1 2024

As of 31 Mar 2024, IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) was held by 266 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 217,101,064 shares. The largest 10 holders included VANGUARD GROUP INC, MHR FUND MANAGEMENT LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Artisan Partners Limited Partnership, and JPMORGAN CHASE & CO. This page lists 267 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

233

Q1 2024 holders

266

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.